Mark R. Hake

Mark R. Hake

Mark R. Hake, CFA is a financial analyst and entrepreneur. He has been a Chartered Financial Analyst (CFA) for 31 years and has owned his own investment management and investment research firms that focused on value stocks, both in the U.S. and overseas.

Mark writes over 600 articles per year on stocks, cryptos, SPACs, convertibles, ETFs, and other financial securities. He has been ranked with 5 stars by TipRanks.com (under “Mark R. Hake”) with an average return of over 22% annually and #36 out of 8,116 writers. Presently he authors articles on Medium.com and other sites.

Mark also invests in public and private equities and has acted as a hedge fund manager and portfolio manager for various money management firms. He has also acted as CFO and Chief Strategy Officer for several fin-tech and software companies.

You can follow Mark on LinkedIn and on TipRanks.

Recent Articles

Rite-Aid Stock Should Benefit From the Company’s Turnaround

Rite Aid stock should benefit from the company's turnaround. It's restructuring strategy will feed through to an eventual increase in Rite Aid stock.

Eldorado Resorts Stock Will Jump When the Caesars Deal Closes

Eldorado Resorts stock will jump when the Caesars merger closes since the cash portion rises each day until the deal is done.

Nikola Stock Defies the Shorts and Maintains Its Massive Valuation

Nikola stock defies the shorts and keeps its massive valuation. Its high price might last if the Badger pickup truck reservations after June 29 are successful.

Carnival Stock Won’t Recover Until It Gets a Firm Sail Date

Carnival won't recover until the company gets a firm sail date. Uncertainty over revenue and a capital raise will push CCL stock lower.

DraftKings Stock Will Get a Draft From Its Secondary Offering

DraftKings stock will get a draft from its higher cash pile. The digital gambling disruptor now has about $1.1 billion in cash that it can use to generate cash flow.

Huge Debt Load Makes Buying American Airlines a Gamble

American Airlines is piling up debt thanks to the coronavirus' impact. But if the airline can avoid bankruptcy, AAL stock will likely soar.

Inovio Pharma’s Next Clinical Results Will be Binary for INO Stock

Inovio Pharma's next clinical results will be a binary event for INO Stock. It will rise or fall based on its Phase 1 results due out by the end of June.

Avoid Virgin Galactic Stock Despite NASA Announcement

Virgin Galactic has big ideas, but it lacks big plans to make money. Until its business model changes, avoid SPCE stock.

5 Cheap Financial Stocks to Buy Right Now

Some of the best cheap stocks to buy now are financial stocks, thanks to their higher-than-average dividends and impressive upside potential.

Under Armour’s Outlook Is Murky and on a Closer Look, UA Stock Is Expensive

Under Armour's outlook is murky and UA stock looks expensive. The stock is likely to fall when Q2 and Q3 losses drag down the company's liquidity, book value and upside.